MEI Pharma announced the acquisition of 929,548 LTC, with a total value of approximately 110 million USD.

Golden Finance reports that MEI Pharma announced the acquisition of 929,548 Litecoins (LTC) at an average purchase price of $107.58, with a total value of approximately $110 million. The company becomes the first publicly listed company in the United States to use Litecoin as a primary reserve asset. In addition, MEI Pharma has partnered with Litecoin founder Charlie Lee and GSR to launch a $100 million institutional treasury strategy.

LTC-1.26%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)